المؤلفون: Jie Yu, Clare Arnott, Brendon L. Neuen, Hiddo L. Heersprink, Kenneth W. Mahaffey, Christopher P. Cannon, Sadiya S. Khan, Abigail S. Baldridge, Sanjiv J. Shah, Yuli Huang, Chao Li, Gemma A. Figtree, Vlado Perkovic, Meg J. Jardine, Bruce Neal, Mark D. Huffman

المصدر: ESC Heart Failure, Vol 8, Iss 2, Pp 1482-1493 (2021)

مصطلحات موضوعية: Diuretics, Canagliflozin, CANVAS Program, Sodium‐glucose cotransporter 2 inhibitor (SGLT2i), Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2055-5822

URL الوصول: https://doaj.org/article/851c1009f53f4b14acb1ca781b58c180

المؤلفون: Yu, J, Zhou, Z, Mahaffey, KW, Matthews, DR, Neuen, BL, Heerspink, HJL, Jardine, MJ, Li, JW, Perkovic, V, Neal, B, Arnott, C

المصدر: urn:ISSN:0167-5273 ; urn:ISSN:1874-1754 ; International Journal of Cardiology, 324, 165-172

مصطلحات موضوعية: Clinical Trials and Supportive Activities, Cardiovascular, Heart Disease, Clinical Research, 3 Good Health and Well Being, Cardiovascular Diseases, Cardiovascular System, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2 Inhibitors, CANVAS program, Cardiovascular mortality, DECLARE- TIMI 58, EMPA-REG OUTCOME, SGLT2i, anzsrc-for: 1102 Cardiorespiratory Medicine and Haematology, anzsrc-for: 1117 Public Health and Health Services

وصف الملف: application/pdf

Relation: http://hdl.handle.net/1959.4/unsworks_73744; https://unsworks.unsw.edu.au/bitstreams/5ce5f64e-fdd5-4095-afbe-fdbf7f3f40bc/download; https://doi.org/10.1016/j.ijcard.2020.09.050

الاتاحة: http://hdl.handle.net/1959.4/unsworks_73744
https://unsworks.unsw.edu.au/bitstreams/5ce5f64e-fdd5-4095-afbe-fdbf7f3f40bc/download
https://doi.org/10.1016/j.ijcard.2020.09.050

المؤلفون: Segundo E. Cieza-Mostacero

مصطلحات موضوعية: Database systems, CANVAS Program, aprendizaje on-line

Relation: https://figshare.com/articles/dataset/Data_UPC_y_PAE/25139774

الاتاحة: https://doi.org/10.6084/m9.figshare.25139774.v2
https://figshare.com/articles/dataset/Data_UPC_y_PAE/25139774

المؤلفون: Oliver Schnell, Lars Rydén, Eberhard Standl, Antonio Ceriello, on behalf of the D&CVD EASD Study Group

المصدر: Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-13 (2017)

مصطلحات موضوعية: Cardiovascular risk, Diabetes, CVOT, DEVOTE, CANVAS program, EXSCEL, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s12933-017-0610-y; https://doaj.org/toc/1475-2840

URL الوصول: https://doaj.org/article/4aaccee354444ec0a72fba5419a1c384

المؤلفون: Zhou, Z, Jardine, M, Perkovic, V, Matthews, DR, Mahaffey, KW, de Zeeuw, D, Fulcher, G, Desai, M, Oh, R, Simpson, R, Watts, NB, Neal, B

المصدر: urn:ISSN:0012-186X ; urn:ISSN:1432-0428 ; Diabetologia, 62, 10, 1854-1867

مصطلحات موضوعية: 32 Biomedical and Clinical Sciences, 3202 Clinical Sciences, Clinical Research, Physical Injury - Accidents and Adverse Effects, Prevention, Patient Safety, Diabetes, Aging, Cardiovascular, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, Aged, Canagliflozin, Diabetes Mellitus, Type 2, Female, Fractures, Bone, Humans, Male, Middle Aged, Single-Blind Method, Sodium-Glucose Transporter 2 Inhibitors, CANVAS Program, Fracture, Sodium glucose co-transporter 2 inhibitors, Type 2 diabetes mellitus, anzsrc-for: 32 Biomedical and Clinical Sciences, anzsrc-for: 3202 Clinical Sciences, anzsrc-for: 1103 Clinical Sciences

وصف الملف: application/pdf

Relation: http://hdl.handle.net/1959.4/unsworks_64742

الاتاحة: http://hdl.handle.net/1959.4/unsworks_64742
https://unsworks.unsw.edu.au/bitstreams/e1340406-484e-4ea2-a81e-9804e4632c3d/download
https://doi.org/10.1007/s00125-019-4955-5

المؤلفون: Ningning Wan, Asadur Rahman, Hirofumi Hitomi, Akira Nishiyama

المصدر: Frontiers in Endocrinology, Vol 9 (2018)

مصطلحات موضوعية: sodium-glucose cotransporter 2 (SGLT2) inhibitor, EMPA-REG OUTCOME trial, CANVAS program, blood pressure, heart rate, sympathetic nervous activity, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/article/10.3389/fendo.2018.00421/full; https://doaj.org/toc/1664-2392

URL الوصول: https://doaj.org/article/6b08271ad5684dbca1ad570a5e6b81ab

المؤلفون: Neal, B, Perkovic, V, Mahaffey, KW, De Zeeuw, D, Fulcher, G, Erondu, N, Shaw, W, Law, G, Desai, M, Matthews, DR

المصدر: urn:ISSN:0028-4793 ; urn:ISSN:1533-4406 ; New England Journal of Medicine, 377, 7, 644-657

مصطلحات موضوعية: Diabetes, Clinical Research, Prevention, Clinical Trials and Supportive Activities, Kidney Disease, Cardiovascular, 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions, Metabolic and endocrine, Aged, Albuminuria, Amputation, Surgical, Canagliflozin, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Disease Progression, Female, Foot, Glomerular Filtration Rate, Hospitalization, Humans, Hypoglycemic Agents, Kidney Diseases, Male, Middle Aged, CANVAS Program Collaborative Group, anzsrc-for: 11 Medical and Health Sciences

وصف الملف: application/pdf

Relation: http://hdl.handle.net/1959.4/unsworks_63143; https://unsworks.unsw.edu.au/bitstreams/4d732b67-638b-4673-b4d8-299db0039eda/download; https://doi.org/10.1056/NEJMoa1611925

الاتاحة: http://hdl.handle.net/1959.4/unsworks_63143
https://unsworks.unsw.edu.au/bitstreams/4d732b67-638b-4673-b4d8-299db0039eda/download
https://doi.org/10.1056/NEJMoa1611925

المؤلفون: Mahaffey, KW, Neal, B, Perkovic, V, De Zeeuw, D, Fulcher, G, Erondu, N, Shaw, W, Fabbrini, E, Sun, T, Li, Q, Desai, M, Matthews, DR, CANVAS Program Collaborative Group

المصدر: 334 ; 323

مصطلحات موضوعية: canagliflozin, clinical trial, diabetes mellitus, primary prevention, secondary prevention, CANVAS Program Collaborative Group, 1103 Clinical Sciences, 1102 Cardiovascular Medicine And Haematology, 1117 Public Health And Health Services, Cardiovascular System & Hematology

Relation: Circulation; http://hdl.handle.net/10044/1/55467; https://dx.doi.org/10.1161/CIRCULATIONAHA.117.032038

الاتاحة: http://hdl.handle.net/10044/1/55467
https://doi.org/10.1161/CIRCULATIONAHA.117.032038

المؤلفون: Neal, B, Perkovic, V, Mahaffey, KW, Fulcher, G, Erondu, N, Desai, M, Shaw, W, Law, G, Walton, MK, Rosenthal, N, Zeeuw, D, Matthews, DR, CANVAS program collaborative group

المصدر: 935 ; 926

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Endocrinology & Metabolism, cardiovascular disease, SGLT2 inhibitor, type 2 diabetes, CANAGLIFLOZIN CARDIOVASCULAR ASSESSMENT, BASE-LINE CHARACTERISTICS, PLACEBO-CONTROLLED TRIAL, SAFETY, CONJUNCTION, RATIONALE, EFFICACY, EVENTS, DESIGN, CANVAS Program collaborative group, 1103 Clinical Sciences

Relation: Diabetes Obesity & Metabolism; http://hdl.handle.net/10044/1/44986; https://dx.doi.org/10.1111/dom.12924

الاتاحة: http://hdl.handle.net/10044/1/44986
https://doi.org/10.1111/dom.12924

المؤلفون: Yu, Jie, Zhou, Zien, Mahaffey, Kenneth W., Matthews, David R., Neuen, Brendon L., Heerspink, Hiddo J. L., Jardine, Meg J., Li, JingWei, Perkovic, Vlado, Neal, Bruce, Arnott, Clare

المصدر: Yu , J , Zhou , Z , Mahaffey , K W , Matthews , D R , Neuen , B L , Heerspink , H J L , Jardine , M J , Li , J , Perkovic , V , Neal , B & Arnott , C 2021 , ' An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials ' , International Journal of Cardiology , vol. 324 , pp. 165-172 . https://doi.org/10.1016/j.ijcard.2020.09.050 ; ISSN:0167-5273

مصطلحات موضوعية: Cardiovascular mortality, EMPA-REG OUTCOME, CANVAS program, DECLARE- TIMI 58, SGLT2i, EMPAGLIFLOZIN, RATIONALE, DESIGN, CANAGLIFLOZIN, DAPAGLIFLOZIN, DISEASE, demo, envir

Relation: https://pure.rug.nl/ws/files/176950491/1_s2.0_S0167527320338316_main.pdf; https://hdl.handle.net/11370/e18cb32f-0fb8-4167-9d2d-a6057ff9741c

الاتاحة: https://pure.rug.nl/ws/files/176950491/1_s2.0_S0167527320338316_main.pdf
https://hdl.handle.net/11370/e18cb32f-0fb8-4167-9d2d-a6057ff9741c

المؤلفون: Yu, Jie, Arnott, Clare, Neuen, Brendon L., Heersprink, Hiddo L., Mahaffey, Kenneth W., Cannon, Christopher P., Khan, Sadiya S., Baldridge, Abigail S., Shah, Sanjiv J., Huang, Yuli, Li, Chao, Figtree, Gemma A., Perkovic, Vlado, Jardine, Meg J., Neal, Bruce, Huffman, Mark D.

المصدر: Yu , J , Arnott , C , Neuen , B L , Heersprink , H L , Mahaffey , K W , Cannon , C P , Khan , S S , Baldridge , A S , Shah , S J , Huang , Y , Li , C , Figtree , G A , Perkovic , V , Jardine , M J , Neal , B & Huffman , M D 2021 , ' Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use : a post hoc analysis from the CANVAS Program ' , ESC ....

مصطلحات موضوعية: Diuretics, Canagliflozin, CANVAS Program, Sodium-glucose cotransporter 2 inhibitor (SGLT2i), psy, envir

Relation: https://pure.rug.nl/ws/files/177295043/ehf2.13236.pdf; https://hdl.handle.net/11370/b21dad93-0c97-410c-97d9-9d845051cd5a

الاتاحة: https://pure.rug.nl/ws/files/177295043/ehf2.13236.pdf
https://hdl.handle.net/11370/b21dad93-0c97-410c-97d9-9d845051cd5a

المؤلفون: Clare Arnott, Jie Yu, Jingwei Li, Kenneth W. Mahaffey, Zien Zhou, Bruce Neal, Brendon L. Neuen, David R. Matthews, Meg Jardine, Hiddo J.L. Heerspink, Vlado Perkovic

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC)

المصدر: International Journal of Cardiology, 324, 165-172. ELSEVIER IRELAND LTD

مصطلحات موضوعية: medicine.medical_specialty, Cardiovascular mortality, DAPAGLIFLOZIN, RATIONALE, Disease, Type 2 diabetes, 030204 cardiovascular system & hematology, Cardiovascular System, DISEASE, 1117 Public Health and Health Services, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, DESIGN, Sodium-Glucose Transporter 2, Internal medicine, medicine, Empagliflozin, Humans, Hypoglycemic Agents, SGLT2i, 030212 general & internal medicine, Dapagliflozin, Sodium-Glucose Transporter 2 Inhibitors, 1102 Cardiorespiratory Medicine and Haematology, Canagliflozin, EMPA-REG OUTCOME, business.industry, CANVAS program, DECLARE- TIMI 58, EMPAGLIFLOZIN, medicine.disease, chemistry, Diabetes Mellitus, Type 2, Cardiovascular System & Hematology, Cardiovascular Diseases, Heart failure, CANAGLIFLOZIN, Cardiology and Cardiovascular Medicine, business, TIMI, Kidney disease, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::235b29bf57ad8cb7b5d31253b0abcf54
http://hdl.handle.net/10044/1/84049

المؤلفون: David R. Matthews, Bruce Neal, Dick de Zeeuw, Meg Jardine, Greg Fulcher, Nelson B. Watts, Richard Oh, Roger Simpson, Kenneth W. Mahaffey, Zien Zhou, Vlado Perkovic, Mehul Desai

المساهمون: Groningen Kidney Center (GKC)

المصدر: Diabetologia
Diabetologia, 62(10), 1854-1867. SPRINGER

مصطلحات موضوعية: 0301 basic medicine, Male, Endocrinology, Diabetes and Metabolism, RATIONALE, PROGRESSION, Disease, Type 2 diabetes, DISEASE, Fractures, Bone, 0302 clinical medicine, DESIGN, Medicine, Single-Blind Method, CARDIOVASCULAR ASSESSMENT, Canagliflozin, Middle Aged, Female, BONE, CANVAS Program, Life Sciences & Biomedicine, medicine.drug, medicine.medical_specialty, 030209 endocrinology & metabolism, Placebo, Article, Nephropathy, 1117 Public Health and Health Services, 03 medical and health sciences, Endocrinology & Metabolism, Diabetes mellitus, Internal medicine, BASE-LINE CHARACTERISTICS, Type 2 diabetes mellitus, Internal Medicine, Humans, Adverse effect, Sodium-Glucose Transporter 2 Inhibitors, Aged, Science & Technology, business.industry, Type 2 Diabetes Mellitus, 1103 Clinical Sciences, medicine.disease, 030104 developmental biology, Fracture, Diabetes Mellitus, Type 2, 1114 Paediatrics and Reproductive Medicine, business, Sodium glucose co-transporter 2 inhibitors

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f05bfd32a4918dd8b2c085f662283ff
https://pubmed.ncbi.nlm.nih.gov/31399845

المؤلفون: Oliver Schnell, Eberhard Standl, Doina Catrinoiu, Stefano Genovese, Nebojsa Lalic, Katarina Lalic, Jan Skrha, Paul Valensi, Antonio Ceriello

المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-6 (2018)

مصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, DEVOTE, CANVAS program, Endocrinology, Diabetes and Metabolism, D&CVD EASD Study Group, Diabetes, CVOT Summit, EXSCEL, 030204 cardiovascular system & hematology, Cardiovascular risk, 3. Good health, CVOT, 03 medical and health sciences, 0302 clinical medicine, lcsh:RC666-701, Commentary, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, ACE

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0a2d17dc813e709f5c820dececa935e
https://doi.org/10.1186/s12933-018-0667-2

المؤلفون: Oliver Schnell, Lars Rydén, Eberhard Standl, Antonio Ceriello, on behalf of the D&CVD EASD Study Group

المصدر: Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-4 (2017)
Cardiovascular Diabetology

مصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, MEDLINE, Alternative medicine, 030209 endocrinology & metabolism, Review, 030204 cardiovascular system & hematology, Outcome (game theory), Glucagon-Like Peptide-1 Receptor, CVOT, 03 medical and health sciences, 0302 clinical medicine, Sodium-Glucose Transporter 2, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Intensive care medicine, Sodium-Glucose Transporter 2 Inhibitors, ACE, Angiology, Clinical Trials as Topic, Dipeptidyl-Peptidase IV Inhibitors, DEVOTE, CANVAS program, business.industry, Published Erratum, Diabetes, EXSCEL, Correction, Heart, Cardiovascular risk, medicine.disease, Diabetes Mellitus, Type 2, Cardiovascular Diseases, lcsh:RC666-701, Cardiology, Cardiology and Cardiovascular Medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1cbaf90f32bed516bb20062b4052baa
https://doi.org/10.1186/s12933-017-0633-4

المؤلفون: Greg Fulcher, Wayne Shaw, Dick de Zeeuw, Gordon Law, Norm Rosenthal, Vlado Perkovic, David R. Matthews, Bruce Neal, Mehul Desai, Ngozi Erondu, Marc K. Walton, Kenneth W. Mahaffey

المساهمون: Groningen Kidney Center (GKC)

المصدر: Diabetes obesity & metabolism, 19(7), 926-935. Wiley
Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Male, Process management, CONJUNCTION, Diabetic Cardiomyopathies, Endocrinology, Diabetes and Metabolism, RATIONALE, Plan (drawing), 030204 cardiovascular system & hematology, PLACEBO-CONTROLLED TRIAL, Cohort Studies, 0302 clinical medicine, Endocrinology, DESIGN, Risk Factors, cardiovascular disease, Medicine, Clinical Trial Design, CANVAS Program collaborative group, Canagliflozin, Class (computer programming), SGLT2 inhibitor, Middle Aged, Cardiovascular Diseases, SAFETY, Female, type 2 diabetes, Drug Monitoring, Life Sciences & Biomedicine, medicine.drug, CANAGLIFLOZIN CARDIOVASCULAR ASSESSMENT, Steering committee, 030209 endocrinology & metabolism, Equivalence Trials as Topic, Patient care, Food and drug administration, EVENTS, Endocrinology & Metabolism, 03 medical and health sciences, Double-Blind Method, Sodium-Glucose Transporter 2, BASE-LINE CHARACTERISTICS, Internal Medicine, Humans, Hypoglycemic Agents, Mortality, Sodium-Glucose Transporter 2 Inhibitors, Aged, Science & Technology, Dose-Response Relationship, Drug, business.industry, Reproducibility of Results, 1103 Clinical Sciences, EFFICACY, Diabetes Mellitus, Type 2, business, Biomarkers, Diabetic Angiopathies, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78fd7f460b50428bf602fb58a9f34afa
https://research.rug.nl/en/publications/46f1e9ef-2099-4eeb-ab60-66ff27b21848